Kenneth J. Martin, Wyeth's (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June.
Kenneth J. Martin, Wyeth’s (Madison, NJ, www.wyeth.com) chief financial officer and vice chairman, has announced plans to leave the company at the end of June. Martin joined the Wyeth in 1984 and has served as the CFO since 2000. The company plans to name a new CFO in advance of Martin’s departure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.